Back to today’s briefing

Story perspectives

AI Reveals 46% Cognitive Decline Reduction in Alzheimer’s Trial

7/18/2025

29 2

Summary

Story summary

In a groundbreaking study published in Nature Communications, researchers harnessed AI to reevaluate data from an Alzheimer’s drug trial, uncovering a remarkable 46% reduction in cognitive decline for early-stage, slow-progressing patients. This innovative method not only refines patient selection for trials but also promises to cut costs and speed up the development of vital dementia treatments.

1 of 1

Story summary

In a groundbreaking study published in Nature Communications, researchers harnessed AI to reevaluate data from an Alzheimer’s drug trial, uncovering a remarkable 46% reduction in cognitive decline for early-stage, slow-progressing patients. This innovative method not only refines patient selection for trials but also promises to cut costs and speed up the development of vital dementia treatments.